Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,422 | 137 | 55.1% |
| Travel and Lodging | $1,973 | 3 | 44.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $1,973 | 3 | $0 (2024) |
| Novo Nordisk Inc | $679.20 | 44 | $0 (2024) |
| Lilly USA, LLC | $302.89 | 20 | $0 (2024) |
| PFIZER INC. | $285.02 | 12 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $192.97 | 7 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $119.97 | 6 | $0 (2024) |
| Amarin Pharma Inc. | $101.47 | 7 | $0 (2021) |
| Esperion Therapeutics, Inc. | $98.28 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $76.57 | 3 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $74.99 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,495 | 31 | INTUITIVE SURGICAL, INC. ($1,973) |
| 2023 | $459.77 | 27 | Lilly USA, LLC ($125.97) |
| 2022 | $236.83 | 11 | Novo Nordisk Inc ($73.14) |
| 2021 | $315.52 | 22 | Novo Nordisk Inc ($83.50) |
| 2020 | $276.21 | 18 | Novo Nordisk Inc ($114.17) |
| 2019 | $281.54 | 21 | Novo Nordisk Inc ($172.49) |
| 2018 | $103.62 | 7 | Merck Sharp & Dohme Corporation ($36.89) |
| 2017 | $226.76 | 3 | PFIZER INC. ($114.63) |
All Payment Transactions
140 individual payment records from CMS Open Payments — Page 4 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/08/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Bone Health | ||||||
| 08/25/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Diabetes | ||||||
| 08/04/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/27/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Diabetes | ||||||
| 07/21/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Bone Health | ||||||
| 07/14/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Obesity | ||||||
| 07/07/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/22/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | CYCLOSET (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Neurology | ||||||
| 06/02/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: Cardiovascular | ||||||
| 05/26/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Cardiovascular | ||||||
| 04/21/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Diabetes | ||||||
| 04/07/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $28.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/23/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Diabetes | ||||||
| 03/10/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/18/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Diabetes | ||||||
| 01/06/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $13.64 | General |
| Category: Cardiovascular | ||||||
| 12/30/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Cardiovascular | ||||||
| 12/16/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/09/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $12.11 | General |
| Category: Cardiovascular | ||||||
| 12/02/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.89 | General |
| 10/29/2020 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Diabetes | ||||||
| 10/21/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Diabetes | ||||||
| 10/06/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Diabetes | ||||||
| 09/29/2020 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Diabetes | ||||||
| 09/16/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 290 | 360 | $56,466 | $16,352 |
| 2022 | 6 | 283 | 330 | $50,251 | $15,256 |
| 2021 | 7 | 236 | 286 | $42,815 | $22,302 |
| 2020 | 10 | 398 | 464 | $58,773 | $25,685 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 120 | 142 | $19,089 | $7,296 | 38.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 115 | $22,773 | $4,201 | 18.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 41 | 41 | $9,446 | $2,506 | 26.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 17 | 17 | $1,969 | $1,223 | 62.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 20 | $820.00 | $641.00 | 78.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $451.00 | $352.55 | 78.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 14 | $1,918 | $132.55 | 6.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 119 | 145 | $19,492 | $7,085 | 36.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 58 | 79 | $15,644 | $3,401 | 21.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 40 | 40 | $9,216 | $1,984 | 21.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 26 | 26 | $3,011 | $1,779 | 59.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 27 | 27 | $1,107 | $848.71 | 76.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 13 | $1,781 | $158.59 | 8.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 55 | 78 | $15,446 | $7,894 | 51.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 84 | 105 | $14,115 | $6,459 | 45.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 39 | 39 | $8,985 | $5,584 | 62.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 15 | 16 | $1,853 | $1,040 | 56.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 12 | 16 | $1,103 | $741.33 | 67.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 18 | 19 | $779.00 | $345.58 | 44.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 13 | 13 | $533.00 | $237.73 | 44.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 106 | 157 | $21,106 | $7,715 | 36.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 58 | 58 | $13,363 | $7,168 | 53.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 46 | 56 | $11,090 | $4,068 | 36.7% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 37 | 37 | $4,285 | $2,195 | 51.2% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 13 | 13 | $3,040 | $1,519 | 50.0% |
About Dr. Si Lam, DO
Dr. Si Lam, DO is a Family Medicine healthcare provider based in Feasterville Trevose, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2015. The National Provider Identifier (NPI) number assigned to this provider is 1992192744.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Si Lam, DO has received a total of $4,395 in payments from pharmaceutical and medical device companies, with $2,495 received in 2024. These payments were reported across 140 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,422).
As a Medicare-enrolled provider, Lam has provided services to 1,207 Medicare beneficiaries, totaling 1,440 services with total Medicare billing of $79,596. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Feasterville Trevose, PA
- Active Since 04/20/2015
- Last Updated 07/07/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1992192744
Products in Payments
- Da Vinci Surgical System (Device) $1,973
- Ozempic (Drug) $239.33
- ELIQUIS (Drug) $130.92
- TRULICITY (Drug) $127.33
- Rybelsus (Drug) $125.72
- Kerendia (Drug) $119.97
- EUCRISA (Drug) $114.63
- MOUNJARO (Drug) $110.26
- Vascepa (Drug) $101.47
- BEVESPI AEROSPHERE (Drug) $100.00
- NEXLETOL (Drug) $98.28
- FARXIGA (Drug) $92.97
- Saxenda (Drug) $77.56
- Wegovy (Drug) $69.38
- JARDIANCE (Drug) $69.01
- Heplisav-B (Drug) $61.46
- CYCLOSET (Drug) $60.59
- EVENITY (Biological) $56.73
- CHANTIX (Drug) $54.20
- JANUVIA (Drug) $50.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Feasterville Trevose
John Mcdonald, D.o, D.O
Family Medicine — Payments: $9,701
Alberto Larrieu, Md, MD
Family Medicine — Payments: $3,114
Sean Duffy, Do, DO
Family Medicine — Payments: $2,905
Dr. Gilbert Kasirsky, D.o, D.O
Family Medicine — Payments: $2,513
Meredith Ray, Md, MD
Family Medicine — Payments: $1,540
Douglas Kimmel, D.o, D.O
Family Medicine — Payments: $1,058